- Home
- MRSN vs OWLT Comparison
MRSN vs OWLT Comparison
Compare MRSN & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- OWLT
- Stock Information
- Founded
- MRSN 2001
- OWLT 2013
- Country
- MRSN United States
- OWLT United States
- Employees
- MRSN N/A
- OWLT N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MRSN Health Care
- OWLT Health Care
- Exchange
- MRSN Nasdaq
- OWLT Nasdaq
- Market Cap
- MRSN 71.9M
- OWLT 73.9M
- IPO Year
- MRSN 2017
- OWLT N/A
- Fundamental
- Price
- MRSN $0.53
- OWLT $5.22
- Analyst Decision
- MRSN Buy
- OWLT
- Analyst Count
- MRSN 7
- OWLT 0
- Target Price
- MRSN $6.00
- OWLT N/A
- AVG Volume (30 Days)
- MRSN 5.4M
- OWLT 28.9K
- Earning Date
- MRSN 03-07-2025
- OWLT 03-04-2025
- Dividend Yield
- MRSN N/A
- OWLT N/A
- EPS Growth
- MRSN N/A
- OWLT N/A
- EPS
- MRSN N/A
- OWLT N/A
- Revenue
- MRSN $34,837,000.00
- OWLT $78,575,000.00
- Revenue This Year
- MRSN N/A
- OWLT $40.64
- Revenue Next Year
- MRSN N/A
- OWLT $20.09
- P/E Ratio
- MRSN N/A
- OWLT N/A
- Revenue Growth
- MRSN N/A
- OWLT 74.76
- 52 Week Low
- MRSN $0.49
- OWLT $3.20
- 52 Week High
- MRSN $6.28
- OWLT $6.25
- Technical
- Relative Strength Index (RSI)
- MRSN 32.86
- OWLT 66.91
- Support Level
- MRSN $0.56
- OWLT $4.64
- Resistance Level
- MRSN $0.82
- OWLT $5.00
- Average True Range (ATR)
- MRSN 0.07
- OWLT 0.22
- MACD
- MRSN 0.03
- OWLT 0.05
- Stochastic Oscillator
- MRSN 8.39
- OWLT 89.56
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.
About OWLT Owlet Inc.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.